India on Wednesday recorded 2.08 lakh new cases of the novel coronavirus, along with 4,157 deaths. India’s active caseload has dropped to 24,95,591 with a dip of 91,191 cases. India’s total recoveries now stand at 2,43,50,816 so far. In the past 24 hours, 2,95,955 patients have recovered, said the Union health ministry. Recoveries continue to outnumber the daily fresh Covid cases for the 13th consecutive day. The recovery rate has increased to 89.66% while the weekly positivity rate is currently at 11.45%, the health ministry said.
States have been urged repeatedly to keep vaccine wastage below 1%, many States like Jharkhand (37.3%), Chhattisgarh (30.2%), Tamil Nadu (15.5%), Jammu & Kashmir (10.8%), Madhya Pradesh (10.7%) are reporting much higher wastage than the national average (6.3%), the Ministry of Health said.
India’s COVID-19 tally had crossed the 20 lakh-mark on August 7 last, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.
It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19 last year.
India crossed the grim milestone of 2 crore on May 4 this year.
|Name of State / UT||Active Cases*||Cured/Discharged/Migrated*||Deaths**|
|Total||Change since yesterday||Cumulative||Change since yesterday||Cumulative||Change since yesterday|
|1||Andaman and Nicobar Islands||254||14||6495||22||104||1|
|8||Dadra and Nagar Haveli and Daman and Diu||439||82||9606||144||4|
|14||Jammu and Kashmir||45630||1807||223619||3999||3609||45|
Meanwhile, Moderna is expecting to launch a single-dose COVID-19 vaccine in India next year and is in talks with Cipla among other Indian firms, while another US giant Pfizer is ready to offer 5 crore shots in 2021 itself but it wants significant regulatory relaxations including indemnification, sources said on Tuesday.
While Moderna has conveyed to Indian authorities that it does not have surplus vaccines to share in 2021, there are limited prospects of Johnson & Johnson exporting its jabs from the US to other countries in the near future, the sources privy to discussions added.
Two rounds of high-level meetings chaired by the Cabinet Secretary were held last week on the availability of vaccines in the global as well as domestic markets as it was felt that there is an urgent need to procure the jabs at a time the country is reeling under an unprecedented second wave of COVID-19 and a widening gap between supply and requirement.